ATE236259T1 - Herstellung einzelner genprodukte eines chimären fusionsproteins durch spaltung mit überall vorkommenden endoproteasen - Google Patents

Herstellung einzelner genprodukte eines chimären fusionsproteins durch spaltung mit überall vorkommenden endoproteasen

Info

Publication number: ATE236259T1
Authority: AT; Austria
Prior art keywords: expression; gene products; fusion protein; sequence encoding; endoproteases
Prior art date: 1998-05-21

Application number

AT99923745T

Other languages

English (en)

Inventor

Johannes Adrianus Gaeken

Farzin Farzaneh

Stephen James Russell

Original Assignee

Cancer Rec Tech Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-05-21

Filing date

1999-05-21

Publication date

2003-04-15

1999-05-21 Application filed by Cancer Rec Tech Ltd filed Critical Cancer Rec Tech Ltd

2003-04-15 Application granted granted Critical

2003-04-15 Publication of ATE236259T1 publication Critical patent/ATE236259T1/de

Links

108090000623 proteins and genes Proteins 0.000 title abstract 5
108020001507 fusion proteins Proteins 0.000 title abstract 2
229920001184 polypeptide Polymers 0.000 abstract 3
102000004196 processed proteins & peptides Human genes 0.000 abstract 3
108090000765 processed proteins & peptides Proteins 0.000 abstract 3
102000002067 Protein Subunits Human genes 0.000 abstract 2
108010001267 Protein Subunits Proteins 0.000 abstract 2
102000004169 proteins and genes Human genes 0.000 abstract 2
101710118538 Protease Proteins 0.000 abstract 1
238000003776 cleavage reaction Methods 0.000 abstract 1
239000000470 constituent Substances 0.000 abstract 1
102000037865 fusion proteins Human genes 0.000 abstract 1
239000000463 material Substances 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
102000039446 nucleic acids Human genes 0.000 abstract 1
108020004707 nucleic acids Proteins 0.000 abstract 1
150000007523 nucleic acids Chemical class 0.000 abstract 1
230000007017 scission Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/55—IL-2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4721—Lipocortins
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5406—IL-4
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5425—IL-9
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5434—IL-12
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5152—Tumor cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Zoology (AREA)
General Health & Medical Sciences (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Medicinal Chemistry (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Toxicology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Immunology (AREA)
Wood Science & Technology (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Physics & Mathematics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Plant Pathology (AREA)
Microbiology (AREA)
Veterinary Medicine (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Saccharide Compounds (AREA)
Sorting Of Articles (AREA)

AT99923745T 1998-05-21 1999-05-21 Herstellung einzelner genprodukte eines chimären fusionsproteins durch spaltung mit überall vorkommenden endoproteasen ATE236259T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9810999.4A GB9810999D0 (en)	1998-05-21	1998-05-21	Materials and methods relating to the expression of genes
PCT/GB1999/001609 WO1999060135A1 (en)	1998-05-21	1999-05-21	Generation of multiple gene products from chimeric fusion proteins by cleavage with ubiquitous endoproteases

Publications (1)

Publication Number	Publication Date
ATE236259T1 true ATE236259T1 (de)	2003-04-15

Family

ID=10832516

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT99923745T ATE236259T1 (de)	1998-05-21	1999-05-21	Herstellung einzelner genprodukte eines chimären fusionsproteins durch spaltung mit überall vorkommenden endoproteasen

Country Status (13)

Country	Link
EP (1)	EP1080206B1 (de)
JP (1)	JP2002515251A (de)
KR (1)	KR20010052383A (de)
CN (1)	CN1308679A (de)
AT (1)	ATE236259T1 (de)
AU (1)	AU753785B2 (de)
CA (1)	CA2333144A1 (de)
DE (1)	DE69906509D1 (de)
ES (1)	ES2201718T3 (de)
GB (1)	GB9810999D0 (de)
ID (1)	ID27206A (de)
NZ (1)	NZ508863A (de)
WO (1)	WO1999060135A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6586411B1 (en) *	2000-08-16	2003-07-01	Mayo Foundation For Medical Education And Research	System for monitoring the location of transgenes
AU7593001A (en)	2000-07-14	2002-01-30	Zycos Inc	Alpha-msh related compounds and methods of use
EP1369128A1 (de) *	2002-06-07	2003-12-10	Procorde GmbH	Glycoprotein VI Inhibitoren und deren therapeutische Verwendung
DE602004028007D1 (de) *	2003-05-14	2010-08-19	Bayer Pharmaceuticals Corp	Interleukin-9 antagonist-muteine und ihre pharmakologischen anwendungsverfahren
WO2005017149A1 (en) *	2003-06-03	2005-02-24	Cell Genesys, Inc.	Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site
US7485291B2 (en) *	2003-06-03	2009-02-03	Cell Genesys, Inc.	Compositions and methods for generating multiple polypeptides from a single vector using a virus derived peptide cleavage site, and uses thereof
FR2856069A1 (fr) *	2003-06-10	2004-12-17	Bionexis	Molecules de ciblage et de liberation de composes therapeutiques et leur utilisation
MX2008000985A (es)	2005-07-21	2008-04-07	Abbott Lab	Expresion de gen multiple que incluye construcciones y metodos sorf (cuadro de lectura abierta simple) con poliproteinas, pro-proteinas y proteolisis.
WO2009032954A1 (en) *	2007-09-04	2009-03-12	The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services	Deletions in domain ii of pseudomonas exotoxin a that reduce non-specific toxicity
US8715964B2 (en)	2008-05-11	2014-05-06	The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services	Expression of IL-12 family heterodimers
WO2011042874A1 (en) *	2009-10-06	2011-04-14	Ecole Polytechnique Federale De Lausanne (Epfl)	Visualization of proprotein convertase activity in living cells and tissues
WO2012031137A2 (en)	2010-09-02	2012-03-08	Mayo Foundation For Medical Education And Research	Vesicular stomatitis viruses
US9951117B2 (en)	2010-09-02	2018-04-24	Mayo Foundation For Medical Education And Research	Vesicular stomatitis viruses
EP3197911A4 (de) *	2014-09-22	2018-06-20	Intrexon Corporation	Verbesserter therapeutische kontrolle von heterodimeren und einkettigen formen von interleukin-12
WO2017062953A1 (en) *	2015-10-10	2017-04-13	Intrexon Corporation	Improved therapeutic control of proteolytically sensitive, destabilized forms of interleukin-12
US11492384B2 (en)	2018-09-17	2022-11-08	Gi Innovation, Inc.	Fusion protein comprising IL-2 protein and CD80 protein, and use thereof
WO2020198145A1 (en) *	2019-03-22	2020-10-01	The Johns Hopkins University	Gene delivery particles to induce tumor-derived antigen presenting cells
BR112023020209A2 (pt)	2021-04-02	2023-12-19	Krystal Biotech Inc	Genoma do vírus do herpes recombinante, vírus do herpes, composição farmacêutica, uso do vírus do herpes ou da composição farmacêutica, método para expressar, realçar, aumentar, ampliar e/ou suplementar os níveis de um polipeptídeo imunomodulatório, método para prover alívio profilático, paliativo ou terapêutico, e, método para tratar câncer
CA3235894A1 (en) *	2021-10-25	2023-05-04	Brile Chung	Compositions and methods for therapeutic delivery

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2000859A6 (es) *	1985-08-12	1988-03-16	Syntex Inc	Un metodo para producir un vector de expresion bacteriana para la expresion de proteinas de fusion
DK0485504T3 (da) *	1989-08-11	1994-04-18	Zymogenetics Inc	Fremgangsmåde til fremstilling af aktiveret protein C ved celledyrkning
WO1997012048A1 (en) *	1995-09-27	1997-04-03	Medical Research Council	Recombinant viruses incorporating a protease cleavable protein

1998
- 1998-05-21 GB GBGB9810999.4A patent/GB9810999D0/en not_active Ceased
1999
- 1999-05-21 ID IDW20002666A patent/ID27206A/id unknown
- 1999-05-21 CA CA002333144A patent/CA2333144A1/en not_active Abandoned
- 1999-05-21 DE DE69906509T patent/DE69906509D1/de not_active Expired - Lifetime
- 1999-05-21 AU AU40508/99A patent/AU753785B2/en not_active Ceased
- 1999-05-21 KR KR1020007013081A patent/KR20010052383A/ko not_active Withdrawn
- 1999-05-21 CN CN99808292A patent/CN1308679A/zh active Pending
- 1999-05-21 NZ NZ508863A patent/NZ508863A/xx unknown
- 1999-05-21 AT AT99923745T patent/ATE236259T1/de not_active IP Right Cessation
- 1999-05-21 WO PCT/GB1999/001609 patent/WO1999060135A1/en not_active Ceased
- 1999-05-21 ES ES99923745T patent/ES2201718T3/es not_active Expired - Lifetime
- 1999-05-21 EP EP99923745A patent/EP1080206B1/de not_active Expired - Lifetime
- 1999-05-21 JP JP2000549741A patent/JP2002515251A/ja active Pending

Also Published As

Publication number	Publication date
WO1999060135A8 (en)	2000-01-13
KR20010052383A (ko)	2001-06-25
CN1308679A (zh)	2001-08-15
GB9810999D0 (en)	1998-07-22
ES2201718T3 (es)	2004-03-16
NZ508863A (en)	2003-03-28
EP1080206A1 (de)	2001-03-07
EP1080206B1 (de)	2003-04-02
ID27206A (id)	2001-03-08
DE69906509D1 (de)	2003-05-08
AU4050899A (en)	1999-12-06
AU753785B2 (en)	2002-10-31
JP2002515251A (ja)	2002-05-28
WO1999060135A1 (en)	1999-11-25
CA2333144A1 (en)	1999-11-25

Legal Events

Date	Code	Title	Description
2003-10-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE236259T1 (de)	2003-04-15	Herstellung einzelner genprodukte eines chimären fusionsproteins durch spaltung mit überall vorkommenden endoproteasen
Baker	1996	Protein expression using ubiquitin fusion and cleavage
CN101253196B (zh)	2012-09-05	通过胰蛋白酶变体切割胰岛素前体
KR860001305B1 (ko)	1986-09-11	특이적 절단 링커를 사용하는 융합 단백질의 제조방법
WO1994018332A3 (en)	1994-10-13	Anthrax toxin fusion proteins and uses thereof
DK0941318T3 (da)	2001-05-21	Håndvægtformede konstruerede ekspressionssystemer til genterapi
KR20170085129A (ko)	2017-07-21	펩티드 생산용 융합 파트너
ATE264393T1 (de)	2004-04-15	Klonierung der prolyl-dipeptidyl-peptidase von aspergillus oryzae
EP1228233B1 (de)	2007-01-10	Verfahren and zusammenstellungen, die renilla gfp enthalten
HU212592B (en)	1996-08-29	Method for producing antibodies genetechnologically
AU2002234863A1 (en)	2002-09-19	Denaturat stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same and their uses
MXPA05012336A (es)	2006-01-30	Procedimiento para producir una proteina dirigida a un plastidio en celulas vegetales.
EP0127658B1 (de)	1987-10-14	Verfahren zur herstellung reifer proteine aus schmelzproteinen hergestellt in pro- oder eukaryotischen zellen
Pilon et al.	1997	Ubiquitin fusion technology: bioprocessing of peptides
WO2003016477A3 (en)	2006-11-30	Insect or83b odorant receptor
EP1458240A4 (de)	2006-01-25	Zur glucoseregulierten produktion von menschlichem insulin in somatischen zelllinien geeignete nukleinsäurekonstrukte
US20050214899A1 (en)	2005-09-29	Removal of N-terminal methionine from proteins by engineered methionine aminopeptidase
EP0955370A3 (de)	2000-12-20	DNAs die für neue fusions-Proteine kodieren und Verfahren zur Herstellung von nützlichen Polypeptiden durch Expression der DNAs
Wong et al.	2018	Escherichia coli: A versatile platform for recombinant protein expression
SE0303093D0 (sv)	2003-11-18	Expression vector, host cell and method for producing fusion proteins
WO2002006485A3 (en)	2003-03-13	47885, a novel human ubiquitin-activating enzyme and uses therefor
ATE354663T1 (de)	2007-03-15	Eine mycobacterium tuberculosis kodierende sequenz zur expression von heterologen proteinen
DE602004020771D1 (de)	2009-06-04	Recombinante igf expressionssysteme
WO2001081584A3 (en)	2002-04-04	27960, a novel ubiquitin conjugating enzyme family member and uses therefor
WO2002024898A3 (en)	2003-03-27	47647, a human lipase and uses therefor